cyclosporine has been researched along with Tauopathies in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ballatore, C; Brunden, KR; Cornec, AS; Gay, B; Hoye, AT; Hyde, E; James, MJ; Lee, VM; Lou, K; Smith, AB; Trojanowski, JQ; Yao, Y | 1 |
| Aiello, G; Kobeissy, F; Kurup, M; Lin, F; Torres, I; Wang, KK; Yadikar, H; Yang, Z; Yost, R | 1 |
| Baker, JD; Becker, S; Blair, LJ; Darling, A; Dickey, CA; Favretto, F; Koren, J; Mandelkow, E; Martin, MD; Nordhues, BA; Sabbagh, JJ; Shelton, LB; Solanki, PK; Sullivan, LE; Sun, Z; Suntharalingam, A; Uversky, VN; Zheng, D; Zweckstetter, M | 1 |
3 other study(ies) available for cyclosporine and Tauopathies
| Article | Year |
|---|---|
Brain-penetrant, orally bioavailable microtubule-stabilizing small molecules are potential candidate therapeutics for Alzheimer's disease and related tauopathies.
Topics: Administration, Oral; Alzheimer Disease; Animals; Biological Availability; Brain; Cell Line; Humans; Mice; Microtubules; Molecular Structure; Pyrimidines; Tauopathies | 2014 |
Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization.
Topics: Animals; Cell Line; Cyclosporine; Glycogen Synthase Kinase 3; Lithium Chloride; Mice; Models, Biological; Okadaic Acid; Phosphorylation; Protein Kinase Inhibitors; Protein Multimerization; Rats; Tauopathies; Triazoles | 2020 |
Human cyclophilin 40 unravels neurotoxic amyloids.
Topics: alpha-Synuclein; Alzheimer Disease; Amyloid; Animals; Blotting, Western; Brain; Cognition Disorders; Cyclophilins; Cyclosporine; Disease Models, Animal; Female; HEK293 Cells; Humans; Male; Mice, Transgenic; Microscopy, Electron, Transmission; Neurodegenerative Diseases; Peptidyl-Prolyl Isomerase F; Protein Aggregates; Protein Aggregation, Pathological; tau Proteins; Tauopathies | 2017 |